Chapter 1. DRUG-ELUTING BALLOON MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. DRUG-ELUTING BALLOON MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. DRUG-ELUTING BALLOON MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. DRUG-ELUTING BALLOON MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. DRUG-ELUTING BALLOON MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. DRUG-ELUTING BALLOON MARKET – By End-User

6.1. Ambulatory Surgical Centers

6.2. Hospitals

6.3. Others

Chapter 7. DRUG-ELUTING BALLOON MARKET – By Product Type

7.1.  Knitted Textile

7.2. Non-Woven Textile

7.3. Woven Textile

Chapter 8. DRUG-ELUTING BALLOON MARKET – By Technology

8.1. EnduraCoat

8.2. FreePac

8.3. TransPac

8.4. Others

Chapter 9. DRUG-ELUTING BALLOON MARKET – By Region

9.1. North America

9.2. Europe

9.3.The Asia Pacific

9.4.Latin America

9.5. Middle-East and Africa

Chapter 10. DRUG-ELUTING BALLOON MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company  8

10.9. Company 9

10.10. Company 10